Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCD-04 for prevention of anthracycline-induced cardiotoxicity in breast cancer
NL-OMON21418Active, not recruiting
- Sponsor
- LTT Bio-Pharma Co., Ltd.
- Start
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Anthracycline Cardiomyopathy and breast cancer comparing PCD-04 arm with Placebo arm (2 arms). Primary endpoints: Safety assessment, Pharmacokinetics and 1 more. Started Sep 2003; status: active, not recruiting.
02
Drugs
alprostadil
03
Conditions
Anthracycline Cardiomyopathybreast cancer
Beyond the preview
Go deeper on NL-OMON21418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21418.